Skip Navigation

COVID-19 Update

Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Tania Jain, M.B.B.S.

Headshot of Tania Jain
  • Director, Adult Chimeric Antigen Receptor T cell Therapy Program for Hematological Malignancies, Sidney Kimmel Comprehensive Cancer Center
  • Assistant Professor of Oncology
Female

Languages: English, Hindi, Punjabi

Expertise

Internal Medicine, Oncology

Request an Appointment

Insurance Information

Maryland Phone

410-955-8964

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Appointment Phone: 410-955-8964
401 N. Broadway
Baltimore, MD 21231 map

The Bunting Blaustein Cancer Research Building

1650 Orleans Street
Baltimore, MD 21287 map

Background

As a physician scientist in the hematological malignancies and stem cell transplantation division with Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins, my focus is on the various aspects of cellular therapy in the treatment of hematological malignancies. My primary research focus is to develop strategies to prevent relapse of hematological malignancies following allogeneic stem cell transplantation.  Additionally, I serve as the director of the adult CAR T program for hematological malignancies as we grow our CAR T program to help patients with advanced hematological malignancies. My academic interest in this space lies in studying the aspects of toxicity of CAR T cell therapy with an aim to improve long term outcomes in these patients. Among hematological malignancies, myeloproliferative disorders are my area of interest and I work to study newer drugs in early phase of development and also its treatment using allogeneic stem cell transplantation. 

...read more

Titles

  • Director, Adult Chimeric Antigen Receptor T cell Therapy Program for Hematological Malignancies, Sidney Kimmel Comprehensive Cancer Center
  • Assistant Professor of Oncology

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MBBS; Government Medical College Patiala (2009)

Residencies

  • Internal Medicine; Detroit Medical Center (2015)

Fellowships

  • Hematology and Oncology; Mayo Clinic Arizona (2018)
  • Memorial Sloan-Kettering Cancer Center (2019)

Board Certifications

  • American Board of Internal Medicine (Hematology) (2018)
  • American Board of Internal Medicine (Internal Medicine) (2015)
  • American Board of Internal Medicine (Medical Oncology) (2018)

Research & Publications

Selected Publications

View all on PubMed

Jain T, Kunze KL, Mountjoy L, Partain DK, Kosiorek H, Khera N, Hogan WJ, Roy V, Slack JL, Noel P, Fauble VDS, Leis JF, Sproat L, Tefferi A, Patnaik MM, Mesa RA, Palmer J. Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis. Blood Cancer J. 2020 Mar 10;10(3):36. doi: 10.1038/s41408-020-0302-9. PubMed PMID: 32157091; PubMed Central PMCID: PMC7064504

Pennisi M, Jain T, Santomasso BD, Mead E, Wudhikarn K, Silverberg ML, Batlevi Y, Shouval R, Devlin SM, Batlevi C, Brentjens RJ, Dahi PB, Diamonte C, Giralt S, Halton EF, Maloy M, Palomba ML, Sanchez-Escamilla M, Sauter CS, Scordo M, Shah G, Park JH, Perales MA. Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management. Blood Adv. 2020 Feb 25;4(4):676-686. doi: 10.1182/bloodadvances.2019000952. PubMed PMID: 32084260; PubMed Central PMCID: PMC7042979

Jain T, Bar M, Kansagra AJ, Chong EA, Hashmi SK, Neelapu SS, Byrne M, Jacoby E, Lazaryan A, Jacobson CA, Ansell SM, Awan FT, Burns L, Bachanova V, Bollard CM, Carpenter PA, DiPersio JF, Hamadani M, Heslop HE, Hill JA, Komanduri KV, Kovitz CA, Lazarus HM, Serrette JM, Mohty M, Miklos D, Nagler A, Pavletic SZ, Savani BN, Schuster SJ, Kharfan-Dabaja MA, Perales MA, Lin Y. Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019 Dec;25(12):2305-2321. doi: 10.1016/j.bbmt.2019.08.015. Epub 2019 Aug 22. Review. PubMed PMID: 31446199.

Jain T, Sauter CS, Shah GL, Maloy MA, Chan J, Scordo M, Avecilla ST, Batlevi Y, Dahi PB, Batlevi CW, Lia Palomba M, Giralt SA, Perales MA. Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma. Leukemia. 2019 Oct;33(10):2540-2544. doi: 10.1038/s41375-019-0476-y. Epub 2019 May 21. PubMed PMID: 31114023

Jain T, Kunze KL, Temkit M, Partain DK, Patnaik MS, Slack JL, Khera N, Hogan WJ, Roy V, Noel P, Leis JF, Sproat LZ, Fauble V, Mesa RA, Palmer J. Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis. Bone Marrow Transplant. 2019 Feb;54(2):204-211. doi: 10.1038/s41409-018-0226-1. Epub 2018 May 24. PubMed PMID: 29795431

Activities & Honors

Honors

  • Kass Award, Infectious Disease Society of America Annual Meeting, 2013
  • American Society of Hematology HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award, 2014
  • ASH Abstract Achievement Award, American Society of Hematology, 2017
  • ASBMT Travel Grant Award, American Society of Blood and Marrow Transplantation, 2018
  • ASBMT Clinical Research Training Course (CRTC) Scholar Award, American Society of Blood and Marrow Transplantation, 2018
  • H Jean Khoury Award for Scholarly Excellence, American Society of Blood and Marrow Transplantation, 2018

Memberships

  • Member, American Society of Hematology, 2013
  • Member, American Society of Clinical Oncology, 2015 - 2018
  • Member, American Society of Transplantation and Cellular Therapy (previously, American Society of Blood and Marrow Transplantation), 2016

Professional Activities

  • Director, Adult Chimeric Antigen Receptor T cell Therapy Program for Hematological Malignancies, The Sidney Kimmel Comprehensive Cancer at Johns Hopkins University, 2019
  • Member, Editorial Board, Immuno Medicine, a Wiley journal, 2019
  • Member, Practice Guidelines Committee, American Society of Transplantation and Cellular Therapy, 2019
  • Vice Chair, Committee on Education, American Society of Transplantation and Cellular Therapy, 2020

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button